跳至主要内容
临床试验/NL-OMON35158
NL-OMON35158已完成不适用

Biodistribution and dosimetry of the newly developed P-gp PET tracer [11C]laniquidar in healthy volunteers - Biodistribution of [11C]laniquidar in healthy volunteers

Vrije Universiteit Medisch Centrum0 个研究点目标入组 6 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age between 18-65 years
  • - Good physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests
  • - RDC diagnosis never mentally ill
  • - Written informed consent of each subject

排除标准

  • - Any clinical significant abnormality of any clinical laboratory test
  • - Any subject who has received any investigational medication within 30 days prior to the start of this study, or who is scheduled to receive an investigational drug
  • - Major psychiatric or neurological disorder
  • - History of alcohol and/or drug abuse (DSM-IV criteria)
  • - History of coagulation problems
  • - Any sign of cardiovascular disease
  • - Current use of any medication, other than contraceptive medication
  • - Breast feeding
  • - Pregnancy
  • - Unable to understand or read the Dutch language

研究者

相似试验